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Abstract
The Social Communication Questionnaire (SCQ) and the Social Responsiveness Scales (SRS) are 
commonly used screeners for autism spectrum disorder (ASD). Data from the Study to Explore 
Early Development were used to examine variations in the performance of these instruments by 
child characteristics and family demographics. For both instruments, specificity decreased as 
maternal education and family income decreased. Specificity was decreased with lower 
developmental functioning and higher behavior problems. This suggests that the false positive 
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rates of the SRS and the SCQ are associated with child characteristics and family demographic 
factors. There is a need for ASD screeners that perform well across socioeconomic and child 
characteristics. Clinicians should be mindful of differential performance of these instruments in 
various groups of children.
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Introduction
The American Academy of Pediatrics (AAP) recommends that all children be screened for 
autism spectrum disorder (ASD) in early childhood (Johnson and Myers 2007). Indeed, 
early identification of children with ASD is critical as it facilitates referral for early 
intervention services, which have been shown to improve outcomes (Connor 1998; Rogers 
1998) and reduce the long term cost of care (Jacobson et al. 1998; Peters-Scheffer et al. 
2012). However, there is little information about the performance of screeners for ASD in 
young children across demographic variables or by child characteristics.
Both the Social Communication Questionnaire (SCQ; Rutter et al. 2003) and Social 
Responsiveness Scale (SRS; Constantino and Gruber 2005) are questionnaires designed for 
detecting risk for ASD. The SCQ was originally designed as a screening tool for children 4 
years of age or older enrolled in epidemiological research or for studies comparing 
individuals with ASD and other clinical groups (Berument et al. 1999; Rutter et al. 2003), 
and it is now used clinically. It was derived from the Autism Diagnostic Interview-Revised 
(ADI-R; Lord and Rutter 1994), a parent interview used to diagnose ASD in combination 
with other measures. The SCQ is strongly correlated with the ADI-R (r = .71, p < .001; 
Berument et al. 1999). The SRS is often used to identify the presence and severity of ASD-
related behaviors (Constantino and Gruber 2005; Constantino et al. 2003a, 2004; 
Constantino and Todd 2005; Duvall et al. 2007; Frazier et al. 2014; Virkud et al. 2009).
Both the SCQ and SRS have good overall psychometric properties. The SCQ has high 
internal consistency (Cronbach’s alpha = 0.87; Rutter et al. 2003). It also has good 
discriminative validity when distinguishing between children with ASD and non-ASD 
diagnoses at all intelligence quotient levels, but particularly when used with children 4 years 
of age or older and children from clinical populations (Berument et al. 1999). The sensitivity 
of the SCQ, or ability to correctly classify children with ASD, is about 96% in samples of 
children without intellectual disability. The specificity of the SCQ, or ability to correctly 
classify children without ASD, is about 80% in samples of children without intellectual 
disability (Rutter et al. 2003). Specificity of the SCQ drops considerably when used with 
children who have intellectual impairments (Berument et al. 1999).
The SRS has high internal consistency (Cronbach’s alpha = 0.76), and has good discriminant 
validity (Constantino 2002). Sensitivity and specificity are 0.85 and 0.75, respectively, when 
the SRS total score of 75 is used as the cutoff (Bölte et al. 2011; Constantino 2002). 
Previous research also suggests that the SRS could be a cost-effective assessment for 
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measuring ASD symptoms in school and clinical settings. Specifically, the SRS has been 
found to be useful at differentiating between children with ASD and those without ASD 
(Cholemkery et al. 2014; Wang et al. 2012). The SRS has also been used to track the severity 
of ASD symptoms over time (Constantino et al. 2009; Ho et al. 2005), and it has been found 
to be useful for assessing response to interventions (Constantino et al. 2009, 2007; 
Constantino and Todd 2003; Pine et al. 2006). However, SRS scores are known to increase 
in the presence of some child behavior challenges, such as Attention Deficit/Hyperactivity 
Disorder (Reiersen et al. 2007), and mood disorders (Pine et al. 2008). Further, child 
behavior problems as measured by the Child Behavior Checklist (CBCL; Achenbach and 
Rescorla 2001) account for a large proportion of the variance in SRS scores (Constantino et 
al. 2003b) suggesting that behavior problems may impact screening performance.
Although the SCQ performs well overall, there are variations in performance depending on 
child age and the cutoff score used. For instance, the SCQ has been found to be less effective 
when the recommended cutoff of ≥ 15 is used to differentiate children younger than 4 years 
of age with and without ASD (Allen et al. 2007; Corsello et al. 2007; Eaves et al. 2006; 
Snow and Lecavalier 2008; Wiggins et al. 2007), and may have a high false positive rate 
(Oosterling et al. 2010a). The performance of the SCQ seems to improve when a cutoff 
score of ≥ 11 or ≥ 13 is used in samples of young children (Allen et al. 2007; Corsello et al. 
2007; Oosterling et al. 2010b; Snow and Lecavalier 2008; Wiggins et al. 2007). Because 
using a cut off of ≥ 11 has been shown to maximize sensitivity and specificity in younger 
children (Wiggins et al. 2007), this lower cut off has often been adopted by large public 
health research studies (Schendel et al. 2012; Wiggins et al. 2015). Also, most studies report 
that the SCQ shows an acceptable sensitivity (≈80%) and less than optimal specificity 
(≈60%) when used to distinguish children with ASD and other developmental disabilities 
(Allen et al. 2007; Eaves et al. 2006; Snow and Lecavalier 2008; Witwer and Lecavalier 
2007).
Likewise, SRS scores are associated with variations in performance across child factors. 
Specifically, higher SRS scores suggest more risk for ASD and are associated with increased 
non-ASD behavior problems, older age, and more impaired language, and cognitive skills in 
children with ASD (Hus et al. 2013). Further, in a German sample, SRS scores were higher 
when used with children with conduct disorder and attention-deficit/hyperactivity disorder 
(Bölte et al. 2008). These findings suggest that behavior problems, increased age, and 
expressive language or cognitive level might reduce the specificity for these instruments 
(Charman et al. 2007). However, it is not known whether the SRS shows variability in 
performance by age as does the SCQ (Wiggins et al. 2007).
The current study expands upon past research by exploring the psychometric properties of 
the SCQ and the SRS in young children enrolled in the Study to Explore Early Development 
(SEED). Specifically, the sensitivity and specificity of the SCQ and SRS were estimated in 
this large community-based sample, and the relationships of SCQ and SRS to child and 
family demographic factors assessed. Child variables included several behavior problems as 
measured by the Child Behavior Checklist (Achenbach and Rescorla 2001) and 
developmental levels as measured by the Mullen Scales of Early Learning (Mullen 1995). 
Family characteristics included household income, maternal education, and maternal race 
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and ethnicity. Based on research that has found variability in the performance for the SCQ 
and SRS, described above, as well as variability in the performance of other autism 
screeners (e.g., Scarpa et al. 2013) we expect to find that both child characteristics and 
family characteristics will impact screening performance of the SCQ and SRS.
Method
Participants
Data for this analysis come from phase I of SEED; data were collected from January 2003 to 
December 2005. SEED is a large case-control study of the risk factors associated with ASD 
that included children with ASD, or developmental delays, and children from the general 
population. Children with ASD and other developmental delays were recruited from a 
variety of clinical and educational sources. Population comparison children were recruited 
from a random sample of birth records. Potential participants were screened for eligibility 
and ASD risk by phone. They then completed paper-and-pencil questionnaires by mail and a 
detailed exposure history by phone prior to in-person evaluation for ASD. See Schendel et 
al. (2012) for complete details about this study, including eligibility, recruitment, case 
ascertainment and study procedures.
Participating families had children 30–68.9 months old and came from catchment areas in 
six states: California, Colorado, Georgia, Maryland, North Carolina, and Pennsylvania. 
California and Colorado were the only sites to recruit Spanish-speaking families; all 
interviews and questionnaires were conducted in either English or Spanish at the preference 
of the family. Informed consent was obtained from all caregivers who participated in the 
study. The current analysis included only those children who completed their developmental 
assessment and for whom a valid Mullen Scales of Early Learning (MSEL) was obtained 
(see measures below), and whose parents completed SCQ, SRS and Child Behavior 
Checklist (CBCL). The Ohio State University (OSU) Autism Rating Scale (OARS; used as 
our analytic “gold standard”), was used as a measure of clinical judgment about presence of 
ASD (OARS-4; The OSU Research Unit on Pediatric Psychopharmacology 2005). Children 
whose parents chose not to complete measures of developmental level or behavior 
challenges were not included in those stratified analyses. The final sample sizes are reported 
with each analysis.
Measures
Demographics—Demographic characteristics were collected during a standardized 
interview with the primary caregiver. Interviewers were trained and ongoing quality control 
assessments ensured reliability (see Schendel et al. 2012). The current analysis used sex of 
child, maternal race, ethnicity, and education, as well as household income as reported by 
the primary caregiver.
Social Communication Questionnaire-Current (SCQ; Rutter et al. 2003)—All 
children were screened for ASD with the SCQ upon entry into SEED. The SCQ has 40 items 
and is appropriate for both verbal and non-verbal children. Total scores range from 0 to 39 
with higher scores representing more social communication impairment. The sensitivity and 
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specificity of the SCQ is maximized at lower cut offs when used with younger children 
(Wiggins et al. 2007) and the SEED used a cutoff score of 11 points to indicate risk for ASD 
(Wiggins et al. 2015). Therefore, the current analysis explored performance of the SCQ 
when cutoff scores of 11, 13 and 15 were used to explore how its performance is affected at 
different cut points.
Social Responsiveness Scale (SRS; Constantino 2002)—The SRS is a 65-item 
parent report measure. The preschool version was used in SEED (Schendel et al. 2012). It 
has five treatment subscales, which can be useful in clinical settings or for developing 
treatment plans (i.e., autistic mannerisms, social awareness, social cognition, social 
communication, and social motivation). Higher SRS scores represent more ASD-related 
behaviors. We used a cutoff T score of 60 as an indication of mild to moderate risk for ASD 
for this analysis. This cutoff results in a 96.8% likelihood of a later clinical diagnosis of 
ASD (Constantino et al. 2007). Although Schanding et al. (2012) did explore optimal cut 
offs for the SRS, this study’s sample had a very large age range. Therefore, we explored 
only the cut off reported in the manual in the current analysis.
OARS-IV (The OSU Research Unit on Pediatric Psychopharmacology 2005)—
The OARS-IV is an instrument that rates the number of ASD symptoms present, the severity 
of ASD symptoms, the clinician degree of certainty that the child has ASD, and the degree 
of impairment associated with ASD. The OARS-IV was completed by the clinician who 
evaluated the child (see Classification of Case Status below for details of evaluation 
process). Clinical judgment was determined by the clinician degree of certainty the child had 
ASD. Out of a total of five points, scores of four or five indicated ASD, and scores of one, 
two, or three indicated non-ASD.
Mullen Scales of Early Learning (MSEL; Mullen 1995)—The MSEL is a measure of 
early learning abilities. The MSEL produces an early learning composite and four domain 
scores: expressive language, fine motor, receptive language, and visual reception. MSEL 
domain t-scores were categorized as Not Below Average (40 and above for t-scores and a 
standard score of 85 and above for the Early Learning Composite) and Below Average 
(below 40 for t-scores and a standard score of below 85 for the Early Learning Composite).
Child Behavior Checklist, Age 1½–5 (CBCL; Achenbach and Rescorla 2001)—
The CBCL measures behavioral and emotional problems in children. It includes seven 
syndrome scales: aggressive behavior, anxious depressed, attention problems, emotionally 
reactive, sleep problems, somatic complaints, and withdrawn, each of which was examined 
in our analyses. CBCL syndrome domain t-scores were categorized as Clinical (60 or 
greater) and Non-Clinical (less than 60).
Classification of Case Status
Data collection procedures were standardized across all sites and were rigorously monitored 
for quality control. All participants began with an eligibility screener and the SCQ 
administered by phone to their primary caregiver. Additional phenotypic information for the 
sampled child, including the CBCL and SRS, were collected by mail or at the in-person 
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clinic visit. Questionnaires that were completed by mail were typically returned within 1–2 
months after the SCQ, but some allowances were made to accommodate the needs of the 
family. Study protocol required all study steps to be completed within 6 months after 
enrollment.
Children were then seen by research-reliable clinicians (administrators who have completed 
advanced training for the Autism Diagnostic Observation Schedule (ADOS; Lord et al. 
2000) and ADI-R and achieved 80 and 90% scoring reliability on those instruments, 
respectively) who conducted a clinic visit to determine case status. Children with lower risk 
for ASD (e.g., SCQ score of ten or less points) were administered the MSEL only, unless the 
child had a previous diagnosis or educational identification of ASD. Children with risk for 
ASD (e.g., SCQ score of 11 or more points) received a full autism assessment [ADOS, ADI-
R, MSEL, and Vineland Adaptive Behavior Scales—Second Edition (Sparrow et al. 2005)].
Children were classified as ASD or non-ASD based on the results of the ADOS, ADI-R and 
clinical judgment, as measured by the OARS-IV described previously. See Wiggins, et al. 
(2015) for complete details about the classification of study participants. Note that not all 
children received an ADOS and ADI-R to determine case status. However, all children in 
this analysis received an in-person developmental evaluation by a trained clinician which 
was the basis for the OARS-4 rating used as our gold standard. Moreover, if after working 
with a child, the clinician believed that a child displayed significant signs of ASD, a full 
evaluation, including the ADOS and ADI-R, could be performed even if the child scored low 
on the SCQ. Per study protocol, this decision was made based on the clinician’s judgment 
after interacting with the child and occurred only three times. Clinicians at all sites had 
advanced degrees and expertise in evaluating autism. All clinicians participated in pre-data 
collection exercises to establish reliability and then participated in quarterly exercises to 
maintain scoring reliability and yearly exercise to maintain administration fidelity. See 
Wiggins et al. (2015) for further details.
Analysis Plan
The overall sample was first characterized using descriptive statistics. To determine the 
performance of the SRS and SCQ as screeners for ASD, we calculated their sensitivity 
(number of true positive/[true positive + false negative]) and specificity (number of true 
negative/[true negative + false positive]) overall and, for the SCQ, at multiple cutoff points. 
This was computed for the total sample first, and then stratified by demographic variables 
and CBCL and MSEL domains. Confidence intervals (95% CIs) were computed for each 
sensitivity and specificity statistic. We used the common formula to calculate CIs for 
binomial proportions: , where n equals the sample size (for sensitivity 
this equals the number of children with ASD and for specificity, the number of children 
without ASD). In cases where the sample sizes were too small to use this formula (i.e., n < 
5) we calculated exact confidence intervals using PROC freq in SAS 9.3.
Previous research as suggested that sensitivity should be between 0.70 and 0.80, and 
specificity should be about 0.8 to be considered an effective screener (e.g., Glascoe 2005). 
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Therefore, we used these benchmarks to indicate adequacy of the screening performance. 
However, given that sensitivity and specificity are continuous measures, we use categorical 
descriptions of performance cautiously. Further, assessing change in sensitivity and 
specificity was conducted based on confidence intervals around the point estimate. In 
general, CIs provide much more information than do significance tests (Cumming 2014) and 
a statistically conservative approach in comparing proportions is to assess whether CIs 
overlap. If they do not, one can assume they are significantly different; although, the inverse 
is not necessarily true (Andrade 2015).
Results
Sample Characteristics
There were 3769 children enrolled in SEED, and 2600 who completed an in person 
developmental assessment. For the purposes of this analysis, children were classified as 
either ASD or non-ASD. Those classified as non-ASD included both children from the 
general population and children who had developmental challenges other than ASD. This 
analysis included 2317 children with completed clinic visit, OARS, SCQ and SRS 
assessments. The average age of the sample was 55.9 months at the time of consent and only 
346 (14.9%) were below 4 years of age. The average age at the time of data collection for 
each of the instruments was 55.0 months for the SCQ, 56.8 months for the Mullen, 58.8 
months for the CBCL and 60.4 months for the SRS. Stratified calculations for the MSEL 
and CBCL included only those children who also completed those additional measures. 
Table 1 shows sample characteristics. Note that all analyses were re-run excluding children 
with non-ASD developmental challenges and those who were under 4 years of age. Results 
did not change remarkably for either of these sensitivity analyses and all relationships 
reported here remained.
Sensitivity and Specificity
Table 2 reports the overall sensitivity and specificity for the whole sample, as well as 
stratified results based on demographic characteristics, with corresponding 95% CIs. 
Overall, sensitivity and specificity were adequate for both measures. SCQ performance 
varied based on the cutoff used. In stratified analyses, there were notable drops in specificity 
for both the SCQ and SRS with lower family income, less maternal education, and African 
American race and Hispanic ethnicity of the mother. As expected due to the known tradeoff 
between sensitivity and specificity, sensitivity was reduced as income increased, and this 
was especially pronounced for SCQ cutoffs of 13 and 15.
Tables 3 and 4 report sensitivity and specificity for the SCQ and SRS stratified by MSEL 
and CBCL domains. There were notable drops in specificity for both instruments when 
children were classified as having below average MSEL performance or behavior problems 
on the CBCL. As expected, sensitivity was reduced for children with average or better 
MSEL language, motor, and visual reception abilities and fewer CBCL behavior problems.
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Discussion
This analysis found important differences in how the SRS and SCQ performed across 
several child and family characteristics. Specifically, both the SCQ and SRS instruments 
became less specific and more sensitive as maternal education and household income 
decreased. These relationships occurred at all cutoffs used for the SCQ. This adds to a 
growing body of literature that shows that ASD screener scores are associated with a number 
of child characteristics (Constantino et al. 2003b; Oosterling et al. 2010a; Pine et al. 2008; 
Reiersen et al. 2007) and that they may perform poorly in those from lower socioeconomic 
status (SES) backgrounds (Scarpa et al. 2013). Importantly, in the case of the SCQ, higher 
cutoffs resulted in somewhat higher specificity, but did not completely mitigate this problem. 
Specificity also dropped for children of non-white mothers; this was particularly pronounced 
for children of African American mothers as indicated by the non-overlapping CIs.
There were also noticeable drops in SCQ and SRS’s specificity for children with 
developmental or behavioral challenges as measured by the MSEL and CBCL as indicated 
by the non-overlapping CIs in Tables 3 and 4. That is, for every MSEL and CBCL subscale/
composite score, the SRS and the SCQ showed reduced specificity for children who scored 
below average or in the clinical range relative to those who scored average or above. When 
stratified on MSEL scales, the SCQ with a cutoff of 15 had somewhat better performance in 
those children with below average development, with most sensitivities and specificities in 
the 70s. However, there was still an average drop of 19.5 percentage points in specificity 
relative to children without developmental challenges. By contrast, the SRS had specificities 
in the upper 40s to mid-50s and an average drop of 35 percentage points between those with 
and without developmental challenges. In the presence of some developmental challenge, 
both instruments seemed to capture those challenges as indicating ASD. Also, even though 
lower cutoffs on the SCQ have been shown to maximize sensitivity and specificity overall, 
we found that specificity suffered more at lower cutoffs. Those using the SCQ with lower 
cutoffs should, therefore, expect higher false positive rates in those with developmental 
concerns.
Similarly, when stratified on CBCL subscales, there were substantial drops in specificity and 
gains in sensitivity for both the SRS and for all cutoffs of the SCQ. The SRS showed the 
largest drop in specificity with most values in the 20s and 30s for children with CBCL 
scores in the clinical range (there were no overlapping CIs in this analysis). The average 
drop in specificity between the non-clinical and clinical groups was approximately 50 
percentage points. The SCQ also had significant drops. Like the results stratified on the 
MSEL, the average drops in specificity were smaller for the cutoff of 15, and greater for 
cutoffs of 13 and 11. As expected, sensitivity tended to be lower and specificity was higher 
for children whose CBCL scores were in the non-clinical range. Thus, these screeners may 
be less able to identify children with ASD who score in the non-clinical range.
Taken together, these findings suggest that the SRS and SCQ effectively detect 
developmental and behavioral challenges, but may not reliably differentiate them from ASD. 
Screening individuals from minority and lower socioeconomic backgrounds is also 
problematic, as these screeners are likely to have unsatisfactory rates of false positives for 
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these groups. If these screeners are routinely used with large populations of minority and 
low-income families, the likely high false positive rate could tax limited resources. Similarly, 
if these screeners are used for research, high false positive rates in these subgroups could 
skew results, or necessitate additional testing to exclude children who do not have ASD, 
again diverting scarce resources. This problem is particularly interesting given the known 
disparities in ASD identification for many minority groups (Autism and Developmental 
Disabilities Monitoring Network 2016). One could argue that higher false-positive rates are 
acceptable when used with under identified groups so as to increase detection of the 
condition. However, that we continue to observe these disparities suggests that additional 
research is needed to determine how to better identify ASD in diverse populations.
These findings do not mean that the SRS and SCQ are ineffective screeners when used in the 
general population. Rather, these data highlight the challenges of successfully identifying 
young children at risk for ASD from low SES backgrounds, as well as those with 
developmental or behavioral challenges. Indeed, these analyses revealed that both the SCQ 
and SRS performed adequately for the combined sample and equally well for both boys and 
girls overall. However, refining these screeners to be more effective, regardless of the child’s 
behavioral presentation and across cultures, could help reduce the impact of false positives.
Further, when used in clinical settings, additional testing is needed to inform the differential 
diagnosis. Likewise, researchers may want to avoid relying on screening results alone to 
confirm diagnosis, especially when cognitive impairment or co-occurring behavioral issues 
are present. Indeed, there has been a longstanding awareness that screening and monitoring 
for ASD is only the first step in the diagnostic process (Filipek et al. 1999). These results 
further highlight the need for a robust clinical evaluation following a positive screening that 
assesses multiple domains of functioning and includes a child observation and parent 
interview (Huerta and Lord 2012). Moreover, the impact of cultural variations and clinician 
interpretation on the clinical findings should be studied further given that the clinician’s 
judgement appears to be formed by more than just core ASD symptoms (Wiggins et al. 
2017).
Limitations
Although these analyses were conducted on a large, diverse sample, there are important 
sample characteristics to consider. In particular, the population-based control group in 
SEED, unlike the ASD and developmental delay groups, over represents white families with 
higher incomes and education, (DiGuiseppi et al. 2016). Given that the population-based 
control group accounted for most of the true negatives, we cannot rule out an upward bias of 
specificity for the White group, and as income and education increase. It is unclear to what 
extent this impacts our results or the generalizability of the findings.
Also, due to the nature of our enrollment criteria, we only included children aged 30–68.9 
months. Both instruments have been validated on much larger age ranges than used here, and 
it is possible that these measures could perform differently with older children. Further, the 
SCQ has not been validated on children under 4, and our sample includes 14.9% of such 
children. However, our findings are not sensitive to the inclusion of young children and our 
findings are noteworthy given that current recommendations suggest screening of infants and 
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young children. That our findings converge with other research that has found demographic 
variability suggests that additional work is needed to determine how best to screen children 
from these groups.
Finally, the SEED protocol permitted up to 6 months to collect all data. While it rarely took 
this long, there is the possibility that some children matured significantly between when the 
SCQ was collected as a screener, and the later instruments (i.e., Mullen, CBCL and SRS). 
However, given that the average age at each of these data collection points was relatively 
close to each other, we do not expect that this impacted our results significantly. 
Nonetheless, some degree of development between data collection points cannot be ruled 
out.
Conclusion
Although both the SCQ and SRS are validated ASD screeners, research and clinical 
programs that rely on these measures should recognize the potential for false positives. 
Specifically, high false positive rates could lead to misclassification if additional diagnostic 
testing is not performed. These challenges could be particularly problematic for community 
settings that have high proportions of minority families or families with low income or low 
maternal education. Our findings underscore the need to refine existing measures or develop 
new instruments to ensure they perform well across all groups.
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